Relationship between phenotype and genotype in growth hormone insensitivity syndrome

Kathryn (Katie) Woods, Clark Ajl, S. Amselem, M. O. Savage

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Growth hormone insensitivity syndrome (GHIS) of genetic origin is associated with many different mutations of the growth hormone receptor (GHR) gene and a recently described genetic defect of the insulin-like growth factor I (IGF-I) gene. Phenotypic and biochemical features were examined in a cohort of 82 patients with GHIS from 23 countries. The mean age of these patients was 8.3 years, their mean height SDS was -6.09 and their median IGF- binding protein-3 (IGFBP-3) SDS was -8.5. In total, 19 of the 82 patients (23%) were growth hormone-binding protein (GHBP)-positive (> 10%). The mean heights in GHBP-negative and CHBP-positive patients were -6.45 SDS and -4.89 SDS, respectively (p <0.001). Sixteen different GHR gene mutations were identified in 27 patients with GHIS. All of these patients had homozygous mutations, except one who had a compound heterozygous mutation. There was no relationship between the type or site within the GHR gene of the mutation and the height SDS or IGFBP-3 SDS of the patients. GHIS is associated with a wide variation in the severity of clinical and biochemical phenotypes. This variation cannot clearly be accounted for by defects: in the GHR gene alone. Other genes or environmental factors must contribute to the control of growth in patients with GHIS.

Original languageEnglish (US)
Pages (from-to)158-163
Number of pages6
JournalActa Paediatrica, International Journal of Paediatrics, Supplement
Volume88
Issue number428
StatePublished - 1999
Externally publishedYes

Fingerprint

Laron Syndrome
Genotype
Phenotype
Somatotropin Receptors
Mutation
Genes
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor I

Keywords

  • Growth hormone
  • Growth hormone insensitivity
  • Growth hormone receptor gene

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Relationship between phenotype and genotype in growth hormone insensitivity syndrome. / Woods, Kathryn (Katie); Ajl, Clark; Amselem, S.; Savage, M. O.

In: Acta Paediatrica, International Journal of Paediatrics, Supplement, Vol. 88, No. 428, 1999, p. 158-163.

Research output: Contribution to journalArticle

@article{8cb89a980f8148ea912641d40af25267,
title = "Relationship between phenotype and genotype in growth hormone insensitivity syndrome",
abstract = "Growth hormone insensitivity syndrome (GHIS) of genetic origin is associated with many different mutations of the growth hormone receptor (GHR) gene and a recently described genetic defect of the insulin-like growth factor I (IGF-I) gene. Phenotypic and biochemical features were examined in a cohort of 82 patients with GHIS from 23 countries. The mean age of these patients was 8.3 years, their mean height SDS was -6.09 and their median IGF- binding protein-3 (IGFBP-3) SDS was -8.5. In total, 19 of the 82 patients (23{\%}) were growth hormone-binding protein (GHBP)-positive (> 10{\%}). The mean heights in GHBP-negative and CHBP-positive patients were -6.45 SDS and -4.89 SDS, respectively (p <0.001). Sixteen different GHR gene mutations were identified in 27 patients with GHIS. All of these patients had homozygous mutations, except one who had a compound heterozygous mutation. There was no relationship between the type or site within the GHR gene of the mutation and the height SDS or IGFBP-3 SDS of the patients. GHIS is associated with a wide variation in the severity of clinical and biochemical phenotypes. This variation cannot clearly be accounted for by defects: in the GHR gene alone. Other genes or environmental factors must contribute to the control of growth in patients with GHIS.",
keywords = "Growth hormone, Growth hormone insensitivity, Growth hormone receptor gene",
author = "Woods, {Kathryn (Katie)} and Clark Ajl and S. Amselem and Savage, {M. O.}",
year = "1999",
language = "English (US)",
volume = "88",
pages = "158--163",
journal = "Acta Paediatrica, International Journal of Paediatrics, Supplement",
issn = "0803-5326",
publisher = "Taylor and Francis Ltd.",
number = "428",

}

TY - JOUR

T1 - Relationship between phenotype and genotype in growth hormone insensitivity syndrome

AU - Woods, Kathryn (Katie)

AU - Ajl, Clark

AU - Amselem, S.

AU - Savage, M. O.

PY - 1999

Y1 - 1999

N2 - Growth hormone insensitivity syndrome (GHIS) of genetic origin is associated with many different mutations of the growth hormone receptor (GHR) gene and a recently described genetic defect of the insulin-like growth factor I (IGF-I) gene. Phenotypic and biochemical features were examined in a cohort of 82 patients with GHIS from 23 countries. The mean age of these patients was 8.3 years, their mean height SDS was -6.09 and their median IGF- binding protein-3 (IGFBP-3) SDS was -8.5. In total, 19 of the 82 patients (23%) were growth hormone-binding protein (GHBP)-positive (> 10%). The mean heights in GHBP-negative and CHBP-positive patients were -6.45 SDS and -4.89 SDS, respectively (p <0.001). Sixteen different GHR gene mutations were identified in 27 patients with GHIS. All of these patients had homozygous mutations, except one who had a compound heterozygous mutation. There was no relationship between the type or site within the GHR gene of the mutation and the height SDS or IGFBP-3 SDS of the patients. GHIS is associated with a wide variation in the severity of clinical and biochemical phenotypes. This variation cannot clearly be accounted for by defects: in the GHR gene alone. Other genes or environmental factors must contribute to the control of growth in patients with GHIS.

AB - Growth hormone insensitivity syndrome (GHIS) of genetic origin is associated with many different mutations of the growth hormone receptor (GHR) gene and a recently described genetic defect of the insulin-like growth factor I (IGF-I) gene. Phenotypic and biochemical features were examined in a cohort of 82 patients with GHIS from 23 countries. The mean age of these patients was 8.3 years, their mean height SDS was -6.09 and their median IGF- binding protein-3 (IGFBP-3) SDS was -8.5. In total, 19 of the 82 patients (23%) were growth hormone-binding protein (GHBP)-positive (> 10%). The mean heights in GHBP-negative and CHBP-positive patients were -6.45 SDS and -4.89 SDS, respectively (p <0.001). Sixteen different GHR gene mutations were identified in 27 patients with GHIS. All of these patients had homozygous mutations, except one who had a compound heterozygous mutation. There was no relationship between the type or site within the GHR gene of the mutation and the height SDS or IGFBP-3 SDS of the patients. GHIS is associated with a wide variation in the severity of clinical and biochemical phenotypes. This variation cannot clearly be accounted for by defects: in the GHR gene alone. Other genes or environmental factors must contribute to the control of growth in patients with GHIS.

KW - Growth hormone

KW - Growth hormone insensitivity

KW - Growth hormone receptor gene

UR - http://www.scopus.com/inward/record.url?scp=0033015191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033015191&partnerID=8YFLogxK

M3 - Article

VL - 88

SP - 158

EP - 163

JO - Acta Paediatrica, International Journal of Paediatrics, Supplement

JF - Acta Paediatrica, International Journal of Paediatrics, Supplement

SN - 0803-5326

IS - 428

ER -